NLRP3 and Parkinson disease: We hypothesize that patients with Parkinson’s disease exhibit decreased serum levels of SIRT1 and Nrf2 and increased NLRP3 inflammasome levels compared with healthy controls, reflecting impaired antioxidant defense and heightened inflammatory activation.